Unexpected Clinical Outcome for Myxoinflammatory Fibroblastic Sarcoma, When Should They Be Considered High Grade?

Authors: Brian K. Sparkman MD, MS, Tuong Vi V. Nguyen MS, Steven Christopher Smith MD, PhD, Harry D. Bear MD, PhD

Source: Journal of Investigative Medicine High Impact Case Reports, Vol 11 (2023)

Subject Terms: Medicine (General), R5-920, Pathology, RB1-214

File Description: electronic resource

Relation: https://doaj.org/toc/2324-7096

Access URL: https://doaj.org/article/56488122b7f64c67bed0d484c0b3c289

Neighborhood disadvantage and biological aging biomarkers among breast cancer patients

Authors: Jie Shen, Bernard F. Fuemmeler, Vanessa B. Sheppard, Harry D. Bear, Renduo Song, Wong-Ho Chow, Hua Zhao

Source: Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/9042551295dd4994b83809014b78f1bd

Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial

Authors: Katya Galactionova, Sibylle Loibl, Paola Salari, Frederik Marmé, Miguel Martin, Michael Untch, Hervé R. Bonnefoi, Sung-Bae Kim, Harry D. Bear, Nicole McCarthy, Karen A. Gelmon, José A. García-Sáenz, Catherine M. Kelly, Toralf Reimer, Masakazu Toi, Hope S. Rugo, Michael Gnant, Andreas Makris, Nicole Burchardi, Matthias Schwenkglenks

Source: Frontiers in Oncology, Vol 12 (2022)

Subject Terms: Penelope-B, Palbociclib, CDKi, (postneo)adjuvant, early breast cancer, cost-effectiveness, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.886831/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/309493d924a94d99901b52801051e924

Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets

Authors: Hussein F. Aqbi, Cara Coleman, Melika Zarei, Saeed H. Manjili, Laura Graham, Jennifer Koblinski, Chunquing Guo, Yibin Xie, Georgi Guruli, Harry D. Bear, Michael O. Idowu, Mehran Habibi, Xiang-Yang Wang, Masoud H. Manjili

Source: Breast Cancer Research, Vol 22, Iss 1, Pp 1-15 (2020)

Subject Terms: Breast cancer, Tumor dormancy, T cells, Cancer immunotherapy, FVBN202 transgenic mouse, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s13058-020-01357-9; https://doaj.org/toc/1465-542X

Access URL: https://doaj.org/article/76d63ae0d42147fd870e77928dba6454

The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer

Authors: Andrea J. Luker, Laura J. Graham, Timothy M. Smith, Carmen Camarena, Matt P. Zellner, Jamie-Jean S. Gilmer, Sheela R. Damle, Daniel H. Conrad, Harry D. Bear, Rebecca K. Martin

Source: BMC Immunology, Vol 21, Iss 1, Pp 1-15 (2020)

Subject Terms: Myeloid derived suppressor cells, DNA methyltransferase inhibitor, Immunotherapy, T lymphocytes, Myelopoiesis, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s12865-020-0337-5; https://doaj.org/toc/1471-2172

Access URL: https://doaj.org/article/8705275c0da24e8995eee5018ccbc1c7

T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy

Authors: Monique Williams, Patrick Dillon, Harry D Bear, Andrew S Poklepovic, Maciej Kmieciak, Kandace P McGuire, Xiaoyan Deng, Dipankar Bandyopadhyay, Michael Idowu, Taylor M Jenkins, Giovanni Archer, Lindsey Gwaltney, Daniel Flora, Daniel Stover, Mary Hackney, Masey Ross, Hetal Vachhani, Raphael Louie, Amelia Grover, Tasnim Rahman, Amber Hendrix

Source: Journal for ImmunoTherapy of Cancer, Vol 13, Iss 2 (2025)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/13/2/e010294.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/3ecc3ea16aa2489083db354e051d32bc

Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity

Authors: Elizabeth Repasky, Harry D Bear, Fang Yuan, Xiaofei Yu, Wenjie Liu, Shixian Chen, Xueqian Cheng, Patrick A Paez, Tuanwei Sun, Chunyan Wei, Joseph W Landry, Andrew S Poklepovic, John R Subjeck, Chunqing Guo, Xiang-Yang Wang

Source: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/9/1/e001595.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/8f4a5899c7754e49ab4f859993919521

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Authors: Maciej Kmieciak, author¹, Amir Toor, author², Laura Graham, author³, Harry D. Bear, author³, Masoud H. Manjili, author¹

Source: Journal of Visualized Experiments. (47)

Availability: http://www.jove.com/video/2381

Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal Study.

Authors: Noran Aboalela, Debra Lyon, R K Elswick, Debra Lynch Kelly, Jenni Brumelle, Harry D Bear, Colleen Jackson-Cook

Source: PLoS ONE, Vol 10, Iss 7, p e0133380 (2015)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: http://europepmc.org/articles/PMC4503400?pdf=render; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/d4f4622e5afd4f8ab5ad52e8eb3d0044

Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling.

Authors: Fatma M Youniss, Gobalakrishnan Sundaresan, Laura J Graham, Li Wang, Collin R Berry, Gajanan K Dewkar, Purnima Jose, Harry D Bear, Jamal Zweit

Source: PLoS ONE, Vol 9, Iss 10, p e109162 (2014)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: http://europepmc.org/articles/PMC4204826?pdf=render; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/498ec0f7c6114c4e9b8b926eef64775f

Walter Lawrence, Jr.: A tribute to a surgical oncologist. “Been there, done that”.

Authors: Harry D. Bear

Source: Journal of Surgical Oncology; May2005, Vol. 90 Issue 3, p109-112, 4p

Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.

Authors: Cynthia S. Chin, Catriona H.T. Miller, Laura Graham, Maryam Parviz, Sharline Zacur, Bina Patel, Angie Duong, Harry D. Bear

Source: International Immunology; Sep2004, Vol. 16 Issue 9, p1283-1294, 12p

Commentary.

Authors: Harry D. Bear

Source: Journal of Surgical Oncology; Jun2003, Vol. 83 Issue 2, p78-79, 2p

This result is not displayed to guests.
Login for full access.